Indoco Remedies Ltd. | Small-cap | Healthcare
₹301.70
2.24%
| Indoco Remedies Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 16.4B
Gross Profit 11.4B 69.65%
Operating Income -145.8M -0.89%
Net Income -779.5M -4.75%
EPS (Diluted) -₹8.46

Balance Sheet Metrics

Total Assets 24.3B
Total Liabilities 14.1B
Shareholders Equity 10.2B
Debt to Equity 1.39

Cash Flow Metrics

Operating Cash Flow -160.9M
Free Cash Flow -1.7B

Revenue & Profitability Trend

Indoco Remedies Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 16.4B 17.9B 16.4B 15.0B 12.2B
Cost of Goods Sold 5.0B 5.8B 5.4B 4.8B 3.7B
Gross Profit 11.4B 12.1B 11.0B 10.2B 8.5B
Operating Expenses 6.7B 6.1B 5.1B 4.3B 3.5B
Operating Income -145.8M 1.4B 2.0B 2.2B 1.6B
Pre-tax Income -743.7M 1.4B 1.9B 2.4B 1.3B
Income Tax 35.8M 387.9M 505.4M 817.7M 389.5M
Net Income -779.5M 970.0M 1.4B 1.5B 930.5M
EPS (Diluted) -₹8.46 ₹10.51 ₹15.42 ₹16.80 ₹10.10

Income Statement Trend

Indoco Remedies Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 10.0B 9.5B 8.1B 7.7B 6.2B
Non-Current Assets 14.3B 11.9B 8.4B 7.1B 6.9B
Total Assets 24.3B 21.4B 16.6B 14.9B 13.2B
Liabilities
Current Liabilities 8.1B 6.1B 4.2B 4.2B 4.1B
Non-Current Liabilities 6.0B 4.2B 2.1B 1.6B 1.4B
Total Liabilities 14.1B 10.3B 6.3B 5.8B 5.5B
Equity
Total Shareholders Equity 10.2B 11.1B 10.3B 9.0B 7.7B

Balance Sheet Composition

Indoco Remedies Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income -83.7M 1.2B 1.9B 2.4B 1.3B
Operating Cash Flow -160.9M 444.7M 1.5B 1.2B 647.3M
Investing Activities
Capital Expenditures 35.5M 16.8M 11.6M 9.4M 2.0M
Investing Cash Flow 159.5M -174.2M -14.9M 35.5M 94.5M
Financing Activities
Dividends Paid -139.0M -207.1M -207.2M -137.9M -27.9M
Financing Cash Flow 2.3B 3.2B 517.7M -281.0M -58.8M
Free Cash Flow -1.7B -2.7B -284.2M 485.0M 53.7M

Cash Flow Trend

Indoco Remedies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 101.34
Forward P/E 21.18
Price to Book 2.51
Price to Sales 1.57
PEG Ratio 21.18

Profitability Ratios

Profit Margin -4.43%
Operating Margin -7.58%
Return on Equity -7.32%
Return on Assets -0.40%

Financial Health

Current Ratio 1.24
Debt to Equity 97.56
Beta 0.39

Per Share Data

EPS (TTM) -₹8.47
Book Value per Share ₹113.36
Revenue per Share ₹191.01

Financial data is updated regularly. All figures are in the company's reporting currency.